Product image of Meropenem Farmalider (Meropenem Anhydrous) supplied by GNH India

Meropenem Farmalider

Active Ingredient:
Meropenem Anhydrous
Origin:
EU

Meropenem Farmalider (Meropenem Anhydrous)

Meropenem, the active ingredient in Meropenem Farmalider, is a carbapenem antibiotic presented as an oral formulation for systemic use. It treats severe bacterial infections such as intra‑abdominal, urinary tract, pulmonary and bloodstream infections in adult patients.

GNH India supplies Meropenem Farmalider as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to EU quality standards and provides reliable sourcing for healthcare institutions.

Manufacturer / TM Owner

Farmalider, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Meropenem is a broad‑spectrum carbapenem used to treat serious bacterial infections in various organ systems.

  • Complicated intra‑abdominal infections: provides bacterial eradication in severe abdominal infections.
  • Complicated urinary tract infections: clears resistant uropathogens causing kidney and bladder infections.
  • Nosocomial pneumonia: treats hospital‑acquired lung infections caused by multidrug‑resistant bacteria.
  • Sepsis: rapidly eliminates bloodstream pathogens in systemic infection.
  • Skin and soft tissue infections: resolves deep tissue infections when other agents fail.

How It Works

  • Meropenem binds to penicillin‑binding proteins on the bacterial cell wall, inhibiting the final transpeptidation step of peptidoglycan synthesis. This disruption weakens the cell wall, leading to osmotic instability and bacterial cell death. The drug exhibits stability against most β‑lactamases, giving it activity against a wide range of Gram‑negative and Gram‑positive organisms.

Side Effects

Meropenem may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Nausea: mild to moderate upset stomach.
  • Diarrhea: may be watery and self‑limiting.
  • Vomiting: occasional episodes after dosing.
  • Headache: transient cranial discomfort.
  • Rash: mild skin erythema.
  • Elevated liver enzymes: transient increase in transaminases.

Serious or Rare Side Effects

  • Anaphylaxis: severe allergic reaction requiring immediate medical attention.
  • Clostridioides difficile colitis: severe intestinal inflammation.
  • Seizures: especially in patients with renal impairment or high doses.
  • Acute renal failure: rapid decline in kidney function.
  • Hepatotoxicity: significant liver injury in rare cases.

Precautions & Warnings

When prescribing Meropenem, clinicians should consider several safety and handling precautions.

  • Renal function: adjust dose in patients with impaired kidney function.
  • Allergy history: avoid in patients with known carbapenem hypersensitivity.
  • Concomitant antibiotics: assess for additive toxicity, especially nephrotoxic agents.
  • Pregnancy and lactation: use only if benefit outweighs potential risk.
  • Microbial resistance: reserve for infections caused by resistant organisms to limit resistance development.
  • Store at below 25°C: keep in the original container, protect from moisture and light.

Avoid Interactions

Meropenem can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid)

  • Valproic acid: may reduce serum levels, increasing seizure risk.
  • Probenecid: can raise meropenem concentrations, heightening toxicity.
  • Cytotoxic agents: potential additive nephrotoxicity.

Moderate Interactions (Monitor Closely)

  • Aminoglycosides: monitor renal function due to combined nephrotoxic potential.
  • Loop diuretics: watch for electrolyte disturbances.
  • Anticoagulants: monitor INR or PT/INR values for altered anticoagulant effect.

Frequently Asked Questions

Meropenem Farmalider is an oral carbapenem antibiotic indicated for the treatment of serious bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, hospital‑acquired pneumonia, sepsis, and severe skin and soft‑tissue infections caused by susceptible organisms.

Meropenem inhibits bacterial cell‑wall synthesis by binding to penicillin‑binding proteins, preventing the cross‑linking of peptidoglycan strands. This leads to a weakened cell wall, osmotic instability and ultimately bacterial cell death, providing rapid bactericidal activity against a broad spectrum of pathogens.

The exact dose and duration of Meropenem Farmalider are determined by the prescribing clinician based on the type and severity of infection, patient weight, renal function, and local susceptibility patterns. No fixed regimen is provided here; the prescriber sets the appropriate dosing schedule.

Safety data for Meropenem in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the Meropenem Farmalider product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and import documentation.

Meropenem offers a broad spectrum of activity similar to other carbapenems like imipenem and ertapenem, but it is often preferred for its stability against many β‑lactamases and its efficacy in treating multidrug‑resistant Gram‑negative infections. Compared with non‑carbapenem options, it provides more reliable coverage for resistant organisms but should be reserved for cases where first‑line agents are ineffective.

Store Meropenem Farmalider at temperatures below 25 °C, in its original packaging, protected from moisture and direct light. Do not expose the product to excessive heat or humidity to maintain its potency and stability.

Meropenem Farmalider is taken orally, usually with a full glass of water. It may be administered with or without food, but consistent intake with respect to meals helps maintain stable plasma concentrations. The exact administration schedule is defined by the prescribing clinician.

Serious risks include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, seizures (particularly in patients with renal impairment or high doses), and acute renal or hepatic injury. Patients should be monitored closely for any signs of these events and seek immediate medical attention if they occur.

Meropenem should be avoided in individuals with a known hypersensitivity to carbapenems or other β‑lactam antibiotics. Patients with severe renal impairment who cannot be dose‑adjusted, or those with a history of severe seizures, should not receive Meropenem unless the benefits clearly outweigh the risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Meropenem Anhydrous

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT